Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11923452 | 0.81 | CYP2D6 (0.44) | KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL15434608 | 0.80 | SMN1; SMN2 (0.56) | KDM4ESMN1; SMN2GLAMEN1KMT2A | |
| SCHEMBL23471084 | 0.78 | CYP2D6 (0.42) | KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL16019413 | 0.78 | CYP2D6 (0.42) | KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL12422516 | 0.78 | CYP3A4 (0.42) | KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL8267288 | 0.76 | GLA (0.56) | KDM4EGLAMEN1KMT2AALDH1A1 | |
| SCHEMBL7361325 | 0.75 | HSD17B10 (0.48) | KDM4ESMN1; SMN2GLAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL9794692 | 0.75 | GLA (0.59) | KDM4EGLAMEN1KMT2AALDH1A1 | |
| SCHEMBL7325836 | 0.74 | GLA (0.54) | SMN1; SMN2GLAMEN1KMT2AALDH1A1 | |
| SCHEMBL19669285 | 0.74 | ALDH1A1 (0.45) | KDM4ESMN1; SMN2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558603-B1 | RETROVIRAL PROTEASE INHIBITORS | MONSANTO CO (US) | 1998-08-26 | — | — | EP | disclosed |
| US-5698569-A | Retroviral protease inhibitors | G. D. SEARLE & CO. (US) | 1997-12-16 | — | — | US | disclosed |
| US-5622949-A | AIDS THERAPY | G. D. SEARLE & CO. (US) | 1997-04-22 | — | — | US | disclosed |
| US-5620977-A | HUMAN IMMUNODEFICIENCY VIRUS | G.D. SEARLE & CO. (US) | 1997-04-15 | — | — | US | disclosed |
| US-5614522-A | SULFONAMIDE AND UREA-CONTAINING HYDROXYETHYLAMINE COMPOUNDS | G.D. SEARLE & CO. (US) | 1997-03-25 | — | — | US | disclosed |
| US-5475013-A | Inhibit human immunodeficiency virus protease | MONSANTO COMPANY (US) | 1995-12-12 | — | — | US | disclosed |
| EP-0558603-A1 | RETROVIRAL PROTEASE INHIBITORS | MONSANTO COMPANY (US) | 1993-09-08 | — | — | EP | disclosed |
| WO-1992008688-A1 | RETROVIRAL PROTEASE INHIBITORS | MONSANTO COMPANY (US) | 1992-05-29 | — | — | WO | disclosed |